BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 27892760)

  • 1. Microbubble-mediated ultrasound drug-delivery and therapeutic monitoring.
    Sennoga CA; Kanbar E; Auboire L; Dujardin PA; Fouan D; Escoffre JM; Bouakaz A
    Expert Opin Drug Deliv; 2017 Sep; 14(9):1031-1043. PubMed ID: 27892760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbubble-Assisted Ultrasound for Imaging and Therapy of Melanoma Skin Cancer: A Systematic Review.
    Avry F; Mousset C; Oujagir E; Bouakaz A; Gouilleux-Gruart V; Thépault RA; Renault S; Marouillat S; Machet L; Escoffre JM
    Ultrasound Med Biol; 2022 Nov; 48(11):2174-2198. PubMed ID: 36050232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound microbubble contrast agents for diagnostic and therapeutic applications: current status and future design.
    Kang ST; Yeh CK
    Chang Gung Med J; 2012; 35(2):125-39. PubMed ID: 22537927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound and microbubble mediated therapeutic delivery: Underlying mechanisms and future outlook.
    Chowdhury SM; Abou-Elkacem L; Lee T; Dahl J; Lutz AM
    J Control Release; 2020 Oct; 326():75-90. PubMed ID: 32554041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sonoporation: Concept and Mechanisms.
    Bouakaz A; Zeghimi A; Doinikov AA
    Adv Exp Med Biol; 2016; 880():175-89. PubMed ID: 26486338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging with ultrasound contrast agents: current status and future.
    Chong WK; Papadopoulou V; Dayton PA
    Abdom Radiol (NY); 2018 Apr; 43(4):762-772. PubMed ID: 29508011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications.
    Klibanov AL
    Invest Radiol; 2006 Mar; 41(3):354-62. PubMed ID: 16481920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted ultrasound contrast agents for ultrasound molecular imaging and therapy.
    van Rooij T; Daeichin V; Skachkov I; de Jong N; Kooiman K
    Int J Hyperthermia; 2015 Mar; 31(2):90-106. PubMed ID: 25707815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted therapeutic applications of acoustically active microspheres in the microcirculation.
    Chappell JC; Price RJ
    Microcirculation; 2006 Jan; 13(1):57-70. PubMed ID: 16393947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbubbles as ultrasound contrast agents and in targeted drug delivery.
    Sheffield P; Trehan A; Boyd B; Wong OL
    Crit Rev Biomed Eng; 2008; 36(4):225-55. PubMed ID: 19961426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress of ultrasound microbubble contrast technology in the diagnosis and treatment of clinical diseases].
    Qiu L; Leng QY; Luo Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 45(6):974-8. PubMed ID: 25571727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From concept to early clinical trials: 30 years of microbubble-based ultrasound-mediated drug delivery research.
    Bouakaz A; Michel Escoffre J
    Adv Drug Deliv Rev; 2024 Mar; 206():115199. PubMed ID: 38325561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound and microbubble-assisted gene delivery: recent advances and ongoing challenges.
    Delalande A; Postema M; Mignet N; Midoux P; Pichon C
    Ther Deliv; 2012 Oct; 3(10):1199-215. PubMed ID: 23116012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound Imaging of Microbubble Activity during Sonoporation Pulse Sequences.
    Keller S; Bruce M; Averkiou MA
    Ultrasound Med Biol; 2019 Mar; 45(3):833-845. PubMed ID: 30638695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of contrast agents to ultrasound.
    Sboros V
    Adv Drug Deliv Rev; 2008 Jun; 60(10):1117-36. PubMed ID: 18486270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic use of ultrasound targeted microbubble destruction: a review of non-cardiac applications.
    Bekeredjian R; Katus HA; Kuecherer HF
    Ultraschall Med; 2006 Apr; 27(2):134-40. PubMed ID: 16612722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidating the mechanisms behind sonoporation with adeno-associated virus-loaded microbubbles.
    Geers B; Lentacker I; Alonso A; Sanders NN; Demeester J; Meairs S; De Smedt SC
    Mol Pharm; 2011 Dec; 8(6):2244-51. PubMed ID: 22014166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of anti-cancer drugs using microbubble-assisted ultrasound in digestive oncology: from preclinical to clinical studies.
    Escoffre JM; Sekkat N; Oujagir E; Bodard S; Mousset C; Presset A; Chautard R; Ayoub J; Lecomte T; Bouakaz A
    Expert Opin Drug Deliv; 2022 Apr; 19(4):421-433. PubMed ID: 35363586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opening of endothelial cell-cell contacts due to sonoporation.
    Beekers I; Vegter M; Lattwein KR; Mastik F; Beurskens R; van der Steen AFW; de Jong N; Verweij MD; Kooiman K
    J Control Release; 2020 Jun; 322():426-438. PubMed ID: 32246975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sonopermeation to improve drug delivery to tumors: from fundamental understanding to clinical translation.
    Snipstad S; Sulheim E; de Lange Davies C; Moonen C; Storm G; Kiessling F; Schmid R; Lammers T
    Expert Opin Drug Deliv; 2018 Dec; 15(12):1249-1261. PubMed ID: 30415585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.